Medifast Announces Fourth Quarter and Full Year 2024 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. LVS
7. SAP
8. CSX
9. LRCX
10. MRK

Go back to Medifast Announces Fourth Quarter and Full Year 2024 Financial Results

Medifast (MED) PT Lowered to $16.50 at DA Davidson

February 19, 2025 1:01 PM EST

DA Davidson analyst Linda Bolton Weiser lowered the price target on Medifast (NYSE: MED) to $16.50 (from $17.00) while maintaining a Neutral rating.

The analyst comments "NEUTRAL-rated MED reported a 4Q24 beat. In December, it launched the Ascend line for people who were... More

Medifast (MED) Tops Q4 EPS by 24c, Misses on Revenue; Offers Q1 Revenue Guidance

February 18, 2025 4:10 PM EST

Medifast (NYSE: MED) reported Q4 EPS of $0.10, $0.24 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $119 million versus the consensus estimate of $131.65 million.

GUIDANCE:

Medifast sees Q1 2025 revenue of $100-120 million, versus the consensus of $130.75... More